Yeda Technology Transfer

Shutterstock

Burning Cancer’s Bridges

04.11.2024

Cancer, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Yeda Technology Transfer

A newly developed antibody-based treatment for the most aggressive type of breast cancer might also be used to treat many other cancers

Combat team: A dendritic cell (right) and a T cell, both from a mouse with skin cancer, combined using the BiCE antibody (yellow)

Standing United: When Immune Cells Join Forces, Cancer Therapy Is More Effective

18.01.2024

Cancer, Immunology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs

A new kind of immunotherapy, based on crosstalk between different immune cells, could pave the way for innovative treatments of cancer and autoimmune...

A glimpse into Bina offices

Your Applied Research Journey Starts Here

31.10.2022

Technology & Applications, Yeda Technology Transfer, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs

Equipped with a team of industry experts, innovation hub Bina invites Weizmann Institute scientists to examine the applicative potential of their...

Microbiome invaders. Illustration: Dell'Ariccia Leibovitch Architects

The Viruses That Fight Disease

04.08.2022

Personalized Medicine, Nutrition, Viruses & Microorganisms, Immunology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs

A surprising precision weapon against Crohn’s and ulcerative colitis

Prof. Yosef Shaul. A lifelong quest

Spiking the Particle

25.04.2022

Viruses & Microorganisms, Disease, Drugs & Diagnostics, Technology & Applications, Yeda Technology Transfer, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs

FDA approves third-generation hepatitis B vaccine based on Weizmann research

Mouse myoblasts after a 24-hour exposure to a molecule blocking the ERK enzyme. The exposure caused the cells to undergo massive fusion, forming muscle fibers (red) with multiple nuclei (blue) // Dr. Tamar Eigler (Prof. Tzahor's research group)

The Meat, the Muscle, and the Motion of Cell Fusion

20.12.2021

Nutrition, Stem Cells, Molecular and Cell Biology, Technology & Applications, Yeda Technology Transfer, Biotechnology

Revelations about muscle stem cell fusion find their way into the food tech industry

Sulfopin

Catching on to Cancer

28.11.2021

Structural Biology, Cancer, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs

A particularly “sticky” molecule could lead to the development of an effective treatment for cancer

Our Customers Want Yellow Bananas

Our Customers Want Yellow Bananas

04.03.2021

Yeda Technology Transfer, Benefiting Humanity

An interview with the CEO of Yeda, Dr. Opher Shapira, who took office in the midst of a pandemic and radical changes in the global economy

Yeda News

Yeda News

01.10.2020

Disease, Drugs & Diagnostics, Yeda Technology Transfer, Biotechnology, Diagnostic Techniques and Drugs

Gene Therapy Firm Enters Collaboration Agreement with Weizmann Lab

bench to bedside

A Faster Path from the Lab Bench to the Clinic

20.05.2020

Yeda Technology Transfer, Benefiting Humanity, Diagnostic Techniques and Drugs

Orchard Innovations is a new joint venture that aims to advance the translation of scientific discovery to the healthcare market

Pages

Top Stories

Credit: Coleen Murphy, Princeton University, Princeton, NJ

Grabbing a Model by the Throat

“Eight Shining Examples of Excellence”

Burning Cancer’s Bridges

Crystalizing Our Comprehension of Malaria

Press Releases

“Eight Shining Examples of Excellence”

The Weizmann Institute of Science Ranked among the World’s Top Ten Academic Institutions

A Discovery to Set Your Heart a-Knocking